StockData
Neuphoria Therapeutics Inc. logo

Neuphoria Therapeutics Inc. (NEUP) stock

NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30
$2.28+0.01 (+0.44%)

Close on Nov 18, 2026Market cap $68.54KP/E –Yield –

Neuphoria Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Neuphoria Therapeutics

Neuphoria Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Neuphoria Therapeutics figures

See a number that looks wrong?